Related Experiment Video

Updated: May 27, 2026

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

[Factor analysis of outcomes during drug-resistant bacterial infection treatment]

Yoichi Hiraki1, Mikako Hiraike, Kiyonori Hanada

  • 1Department of Pharmacy, National Hospital Organization Kumamoto Medical Center.

Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases
|November 29, 2011
PubMed

Insights

Advanced age and tracheal intubation increase risks for drug-resistant bacterial infections like MRSA and PRSP. Identifying specific causes like pneumonia, sepsis, and IVH is crucial for developing effective preventive measures.

Area of Science:

  • Infectious Diseases
  • Clinical Microbiology
  • Epidemiology

Context:

  • Drug-resistant bacterial infections pose significant challenges in healthcare settings.
  • Analysis conducted across 54 National Hospital Organization facilities.
  • Focus on Methicillin-resistant Staphylococcus aureus (MRSA) and Penicillin-resistant Streptococcus pneumoniae (PRSP).

Purpose:

  • To identify factors associated with poor outcomes in patients with drug-resistant bacterial infections.
  • To determine the etiological causes and risk factors for specific resistant bacteria.
  • To inform the development of targeted preventive strategies.

Summary:

  • Elderly patients (≥75 years) and those with tracheal intubation showed significantly higher odds of MRSA and PRSP infections.
  • Pneumonia and sepsis were identified as key factors for MRSA, while Intravenous hyperalimentation (IVH) and urinary-tract infections were linked to Multi-drug resistant Pseudomonas aeruginosa (MDRP).
  • Odds ratios indicated increased risk with advanced age and tracheal intubation for MRSA and PRSP.

Impact:

  • Findings highlight the need for specific preventive measures tailored to identified risk factors.
  • Clarifying the role of each factor is essential for improving treatment outcomes.
  • Data can guide clinical practice and public health initiatives to combat antimicrobial resistance.

More Related Videos

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes03:53

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes

Published on: April 19, 2024

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Factors Affecting Drug Biotransformation: Biological01:19

Factors Affecting Drug Biotransformation: Biological

Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...